Another New Mexico Senate committee has approved a bill to establish a therapeutic psilocybin program in the state.
Members of the Senate Judiciary Committee on Wednesday advanced the legislation from Sen. Jeff Steinborn (D), with only one member of the body—Sen. Katy Duhigg (D)—opposed. This comes about a month after the measure unanimously advanced through the Senate Tax, Business and Transportation Committee.
“Psilocybin mushroom has been researched and proven to be medically efficacious in a variety of ways,” Steinborn told the panel. “We developed this legislation…with the Department of Health. We spent much of the last six months going over this bill—every single word of this bill—with advocates [and] leading people all the way up to to the top of the executive branch.”
If enacted, the Medical Psilocybin Act would allow patients with certain qualifying conditions to access the psychedelic and use it under the guidance of a licensed healthcare provider.
The measure says its purpose “is to allow the beneficial use of psilocybin in a regulated system for alleviating qualified medical conditions,” including major treatment-resistant depression, PTSD, substance use disorders and end-of-life care. The state Department of Health would be able to approve additional conditions.
Therapy would consist of
Read full article on Marijuana Moment
